|
⚲
|
| Keyboard |
| Health Catalyst Capital Management LLC
✚
|
|
|---|---|
| CRD # | 282602 |
| SEC # | 801-119194 |
| CIK # | |
| AUM | 339.0 M (2026-04-28) |
| Employees | 4 (100% Investors, 0% Brokers) |
| Fees | |
| Minimum | |
| Phone | 212-752-2225 |
| Address | 515 Madison Avenue New York, NY 10022 |
| Source | [IAPD] [Website] [Twitter] [LinkedIn] |
| Total AUM ($M) |
|---|
| Fees and Compensation — Form ADV Part 2A (4/28/2026) [Brochure] |
|---|
Item 5 – Fees and Compensation Health Catalyst Capital generally charges the Funds an annual management fee, payable quarterly in advance. The following is a summary of the methods used to calculate the management fee paid to Health Catalyst Capital, by the Funds: Fund I: During the period commencing on the initial closing date and ending on the rampdown date, the management fee shall equal 0.625% per fiscal quarter (equal to 2.5% per annum) of the Limited Partners’ capital commitments. For the period beginning on the rampdown date until the tenth anniversary of the last day of the calendar quarter, the management fee shall be equal to the percentage used in the prior twelve month period reduced by 10.0%, but not less than 1.0% per annual period, of invested capital. For the period beginning after this and thereafter, the management fee shall be 1% of invested capital annually (0.25% per fiscal quarter) as further disclosed in such Fund’s Offering Document. Fund II: During the period commencing on the effective date and ending on the rampdown date, the management fee shall equal 0.50% per fiscal quarter (equal to 2.0% per annum) of the Limited Partners’ capital commitment. For the period beginning on the rampdown date until the tenth anniversary of the last day of the calendar quarter, the management fee shall be equal to the percentage used in the prior twelve month period reduced by 10.0%, but not less than 1.0% per annual period, of invested capital. For the period beginning after this and thereafter, the management fee shall be 1% of invested capital annually (0.25% per fiscal quarter) as further disclosed in such Fund’s Offering Document. Continuation Fund I: During the period commencing on the initial closing date, the management fee shall equal 0.1875% per fiscal quarter (equal to 0.75% per annum) of invested capital as further disclosed in such Fund’s Offering Document. CFG – Elevance One: During the period commencing on the initial closing date, an annual management fee shall equal 0.25% per fiscal quarter (equal to 1.00% per annum) of invested capital as further disclosed in such Fund’s Offering Document. The Annex Funds do not charge an annual management fee. Health Catalyst Capital may also receive advisory fees, consulting fees, break-up fees, directors’ fees, monitoring fees, and transaction fees at the time of investment from and with respect to the portfolio companies in which the Funds invest. Fees paid to Health Catalyst Capital are generally shared with Fund I or Fund II and its Limited Partners through reductions or off-sets against management fees that would otherwise be payable to Health Catalyst Capital, as further disclosed in the relevant Fund’s Offering Document. The Funds will also be responsible for payment of organizational expenses, subject to a cap, pursuant to the Offering Documents. Health Catalyst Capital’s fees and compensation arrangements vary among the Investors in the Funds. The specific terms of such arrangements are established by Health Catalyst Capital, and are set forth in each Fund’s Offering Documents and side letter arrangements, as applicable. Health Catalyst Capital generally will be responsible for normal overhead attributable to its activities, including salaries and employee benefits of employees, office expenses and office rent and utilities. Each Fund bears the expenses set forth in its Offering Documents. Consultants and employees of Health Catalyst Capital may from time-to-time perform paid services to Funds managed by the Adviser and portfolio companies of those Funds. |
| Account Minimums and Types of Clients — Form ADV Part 2A (4/28/2026) [Brochure] |
|---|
Item 7 – Types of Clients Health Catalyst Capital provides investment advice solely to its Funds. Investors in the Funds must generally be “accredited investors” as that term is defined in Rule 501(a) of Regulation D of the Securities Act of 1933 and “qualified purchasers” within the meaning of Section 2(a)(51) and Rule 2a51-1 under the Investment Company Act of 1940, as applicable. Fund Investors are required to commit or contribute certain minimum capital amounts to become investors in the Funds. Generally, the minimum capital commitment to each Fund is $1 million, although the General Partner reserves the right to accept capital commitments of a lesser amount. The General Partner has committed in the aggregate at least 1% of the total capital commitments to each of Fund I, Fund II, and the Annex Fund. |
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| PE | CFG - Elevance One LP | [2026-03-30] | 103.8 M | 103.8 M |
| Offered $103,763,908 · Filed 2025-10-06 (D) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Duration One year or less · Net Assets Not Applicable | ||||
| PE | Health Catalyst Capital Annex Fund II LP | [2025-03-30] | 4.0 M | 4.1 M |
| Offered $4,000,000 · Filed 2024-12-06 (D) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Minimum $4,000,000 · Duration One year or less · Revenue Decline to Disclose | ||||
| PE | Health Catalyst Capital Continuation Fund I LP | [2024-10-22] | 17.1 M | |
| Filed 2024-08-05 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| PE | Health Catalyst Capital Annex Fund I LP | [2022-03-29] | 10.0 M | 7.2 M |
| Offered $10,000,000 · Filed 2021-12-02 (D) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Minimum $9,723 · Duration One year or less · Revenue Decline to Disclose | ||||
| PE | Health Catalyst Capital II LP | [2020-03-30] | 50.8 M | 140.0 M |
| Offered $275,000,000 · Filed 2020-05-29 (D/A) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Minimum $50,000 · Remaining $224,247,500 · Duration More than one year · Revenue Decline to Disclose | ||||
| PE | HCC Coinvest QBD 18 LP | [2019-03-30] | 0.3 M | |
| Filed 2018-12-04 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Net Assets Decline to Disclose | ||||
| PE | Health Catalyst Capital LP | [2016-02-11] | 27.8 M | 66.9 M |
| Offered $100,000,000 · Filed 2016-12-23 (D/A) · Exemption 506(b), 3(c), 3(c)(1) · Remaining $72,211,055 · Duration More than one year · Revenue Decline to Disclose | ||||
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 6 | 339.0 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 6 | 339.0 |
| By Discretionary | ||
| Discretionary | 6 | 339.0 |
| Non-Discretionary | 0 | 0.0 |
| Total | 6 | 339.0 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.0 | |
| United States Persons | 339.0 | |
| Total | 6 | 339.0 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Charles Boorady | Executive Officer | 31 | 3 | |
| Daniel Ross | Executive Officer | 15 | 3 | |
| Health Catalyst Associates Annex LLC | Director | 2 | 1 | |
| Health Catalyst Associates LLC | Director | 1 | 1 | |
| Health Catalyst Capital Continuation Fund GP I LLC | Director | 1 | 1 | |
| Health Catalyst Associates II LLC | Director | 1 | 1 |
| Firm Profile (Form ADV) | |
|---|---|
| Serves | Institutional |
| Fund Types | Private Equity |
| LEI | N/A |
| Comparable Firms | State | AUM |
|---|---|---|
|
Melodeon Capital Partners LP
✚
|
FL | 340.6 M |
|
Marathon Management Partners LLC
✚
|
CA | 340.0 M |
|
Empeiria Capital Management LLC
✚
|
OH | 339.4 M |
|
HCIP Advisors LLC
✚
|
TN | 339.3 M |
|
Flexis Capital LLC
✚
|
FL | 339.1 M |
|
Riverspan Partners LP
✚
|
IL | 338.6 M |
|
Novo Holdings US Investment Advisor Inc
✚
|
MA | 338.6 M |
|
Variant Equity Advisors LLC
✚
|
CA | 338.4 M |
|
Augment Infrastructure Managers Advisory LLC
✚
|
MD | 337.1 M |
|
Valspring Capital Management LP
✚
|
336.9 M |